 |
answer text |
<p>From April 2013, NHS England assumed responsibility for commissioning adult specialist
neurosciences services, including the majority of services for patients with Parkinson's
disease, with some being the responsibility of clinical commissioning groups.</p><p>
</p><p>NHS England has advised that it does not routinely fund Duodopa (co-careldopa)
for the treatment of Parkinson's disease. Clinicians can submit individual funding
requests for this treatment on behalf of their patients as per NHS England's individual
funding requests standard operating procedure, which is found at the following link:</p><p>
</p><p>www.england.nhs.uk/wp-content/uploads/2013/04/cp-04.pdf</p><p> </p><p>NHS England
has advised that its individual funding request process is monitored against the standard
operating procedure to ensure that referring clinicians are informed of outcomes in
a timely manner.</p><p><strong> </strong></p><p>Treatments for Parkinson's are largely
drug based and there is a choice of therapies available. <em> Parkinson's disease:
Diagnosis and management in primary and secondary care</em>, published by the National
Institute for Health and Care Excellence in 2006, makes it clear that communication
with people with Parkinson's disease should be aimed towards empowering them to participate
in the judgements and choices about their own care. With regard to decisions about
the drugs available for treatment of the disease in its later stages, the guidance
states that the patient preference should be taken into account, once they have been
informed of the short- and long-term benefits and drawbacks of the different types
of drugs available.</p><p> </p><p>To reduce avoidable harm, through the Mandate we
have asked NHS England to make measurable progress by 2015 to embed a culture of patient
safety in the NHS including through improved reporting of incidents. The NHS Outcomes
Framework contains a range of indicators designed to measure progress in this area
of care which will be relevant to patients with all conditions, including, Parkinson's
disease.</p>
|
|
